Cold Pulsatile Perfusion in Asystolic donor Renal Transplantation

ISRCTN ISRCTN95022818
DOI https://doi.org/10.1186/ISRCTN95022818
Secondary identifying numbers N/A
Submission date
31/03/2005
Registration date
10/05/2005
Last edited
04/02/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Kidneys from deceased organ donors need to be preserved out of the body to allow time for them to be allocated to a recipient, transported to the recipient centre, and for the recipient to be brought in and prepared for surgery. Typically this takes 12 to 18 hours. Traditionally preservation has been achieved by simply flushing the kidneys with a special preservation solution and placing them in a container of ice. An alternative is to put the kidney on a machine to continuously flush preservation fluid through the kidney until it is time to transplant the kidney into a recipient. The aim of this study is to see which method is superior for kidneys donated by deceased organ donors after circulatory death (DCD).

Who can participate?
Patients aged 18 and over undergoing transplantation of a kidney from a deceased organ donor.

What does the study involve?
Donated kidneys are randomly allocated such that one kidney of a pair is placed on the perfusion machine while the other is flushed and stored in ice until transplantation. Both kidneys of a pair are transplanted at the same centre. The transplant recipients are then followed up to see whether the kidney worked immediately or whether there was a delay in it starting normal function – around half of kidneys from DCD donors do not work immediately and the recipient needs to continue on dialysis until it does work.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
Addenbrooke's Hospital (UK)

When is the study starting and how long is it expected to run for?
August 2006 to February 2009

Who is funding the study?
Novartis Pharmaceuticals and Organ Recovery Systems

Who is the main contact?
Mr Christopher Watson

Contact information

Mr Christopher Watson
Scientific

Department of Surgery
Box 202
Addenbrooke's Hospital
Hills Road
Cambridge
CB2 2QQ
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a patient information sheet
Scientific titleA multicentre randomised controlled study of cold Pulsatile Perfusion in Asystolic donor Renal Transplantation
Study acronymPPART
Study hypothesisPrimary objective:
To evaluate the effect of machine perfusion on the incidence of primary function post renal transplantation.

Secondary objective:
To evaluate the cost effectiveness of machine perfusion in asystolic donor kidney transplantation.
Ethics approval(s)The London Research Ethics Committee (REC), 02/02/2006, ref: 05/MRE02/74). Last ethics progress report dated 05/03/2008: favourable ethical opinion given 19/03/2008.
ConditionKidney preservation prior to transplantation
InterventionMachine perfusion of the kidney before transplantation versus simple cold storage
Intervention typeProcedure/Surgery
Primary outcome measure1. Incidence of delayed graft function (need for dialysis in the first 7 days)
2. Calculated glomerular filtration rate (GFR) (MDRD technique) at 7 days
Secondary outcome measures1. Patient survival
2. Graft survival
3. Renal function measured using calculated GFR
4. Never function rate
5. Time to last dialysis post transplant
6. Acute rejection incidence
7. Cost comparison at one and five years
Overall study start date18/08/2006
Overall study end date28/02/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants205
Participant inclusion criteriaSubjects (aged 18 years and over, either gender) undergoing transplantation of a kidney from a non-heart-beating (asystolic) cadaver organ donor.
Participant exclusion criteriaAdded 24/02/2009:
1. Lack of informed consent
2. Positive cross-match
3. Previous recipient of non-renal transplant
Recruitment start date18/08/2006
Recruitment end date28/02/2009

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Addenbrooke's Hospital
Cambridge
CB2 2QQ
United Kingdom

Sponsor information

Addenbrooke's Hospital (UK)
Hospital/treatment centre

Hills Road
Cambridge
CB2 2QQ
England
United Kingdom

Website http://www.cuh.org.uk/addenbrookes/addenbrookes_index.html
ROR logo "ROR" https://ror.org/055vbxf86

Funders

Funder type

Hospital/treatment centre

Addenbrooke's Hospital (UK) - transplant research fund

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2010 Yes No

Editorial Notes

04/02/2016: Publication reference added.

On 24/02/2009 this record has been amended to include new start and end dates; the initial information at time of registration was as follows:
Initial overall trial start date: 01/10/2005
Initial overall trial end date: 31/10/2013